Pancreatic cancer represents one of the most lethal cancer types worldwide, with a 5-year
survival rate of less than 5%. Due to the inability to diagnose it promptly and the lack of …

Pancreatic cancer is an aggressive cancer with a poor prognosis and an overall 5-year
survival rate of less than 5%. Management has not improved significantly over the last 30 …

Novel and combinatorial treatment methods are becoming sought after entities in cancer
treatment and these treatments are even more valuable for pancreatic cancer. The scientists …

Pancreatic cancer is a devastating gastrointestinal tumor with limited Chemotherapeutic
options. Treatment is restricted by its poor vascularity and dense surrounding stroma …

Pancreatic cancer (PC) is notoriously difficult to diagnosis and properly stage resulting in
incorrect primary treatment. Diagnostic and prognostic biomarkers are desperately needed …

Simple Summary The 8th edition of the AJCC staging system for pancreatic cancer has been
validated for pathological staging; however, its suitability for clinical staging is still uncertain …

Splicing factor 3b subunit 4, a critical component of pre-message RNA splicing complex, has
been reported to play an important part in the tumorigenesis. However, the expression …

Mesothelioma is a rare cancer caused by exposure to asbestos. Belgium has a known long
history of asbestos production, resulting in one of the highest mesothelioma mortality rates …

The abnormally activated hedgehog (Hh) signaling pathway is involved in the regulation of
proliferation and apoptosis in pancreatic cancer cells, while its exact molecular mechanism …

Background The gap in treatment and health outcomes after diagnosis of pancreatic cancer
is a major public health concern. We aimed to investigate the differences in the health …